Authors

  • Yodgorova N.T., Abdumannobov A.A., Elmo'minova R.S., Xudoyberdiyeva M.Sh.

Keywords:

klebsiella pneumoniae, antibiotiklarga chidamlilik, karbapenemga chidamlilik, bakteriemiya, siydik yo‘llari infeksiyasi, virulentlik, bakteriofag terapiyasi.

References

1. Bulman ZP, Krapp F, Pincus NB, Wenzler E, Murphy KR, Qi C, Ozer EA, Hauser AR. Genomic Features Associated with the Degree of Phenotypic Resistance to Carbape-nems in Carbapenem-Resistant Klebsiella pneumoniae. mSystems. 2021 Oct 26; 6(5): e0019421. doi: 10.1128/mSys¬tems.00194-21. Epub 2021 Sep 14. PMID: 34519526; PMCID: PMC8547452.

2. Cheung BH, Alisoltani A, Kochan TJ, Lebrun-Corbin M, Nozick SH, Axline CM, Bachta KE, Ozer EA, Hauser AR. Genome-wide screens reveal shared and strain-specific ge¬nes that facilitate enteric colonization by Kleb¬siella pneumoniae. bioRxiv [Preprint]. 2023 Aug 31:2023.08.30.555643. doi: 10.1101/ 2023.08.30.555643. Update in: mBio. 2023 Dec 19; 14(6):e0212823. doi: 10.1128/mbio. 02128-23. PMID: 37693543; PMCID: PMC10 491162.

3. Chuchalin AG, Onishchenko GG, Ko-losov VP, Kurganova OP, Tezikov NL, Manakov LG, Gulevich MP, Perelman YM. Pnevmoniya: regional'nyi opyt organizatsii profilaktiches¬kikh programm [Pneumonia: Regional expe¬rience with prevention programs]. Ter Arkh. 2016;88(8):87-92. Russian. doi: 10.17116/te¬rarkh201688887-92. PMID: 27636932.

4. Freitas AB, Rezende HHA, de Souza GRL, Gonçalves PJ. Photodynamic inactivation of KPC-producing Klebsiella pneumoniae dif¬ficult-to-treat resistance (DTR) by a cationic porphyrin. J Photochem Photobiol B. 2025 Apr;265:113133. doi: 10.1016/j.jphoto¬biol. 2025.113133. Epub 2025 Feb 20. PMID: 39987860.

5. Hazen TH, Adediran T, Hitchcock S, O'Hara LM, Pineles L, Michalski JM, Johnson JK, Nguyen MH, Calfee DP, Miller LG, Harris AD, Rasko DA. Clinical and Bacterial Characte¬ristics Associated with Glove and Gown Conta¬mination by Carbapenem-Resistant Klebsiella pneumoniae in the Health Care Setting. Micro¬biol Spectr. 2023 Aug 17;11(4):e0177523. doi: 10.1128/spectrum.01775-23. Epub 2023 Jun 8. PMID: 37289087; PMCID: PMC1043 4059.

6. Hetland MAK, Winkler MA, Kasper-sen HP, Håkonsholm F, Bakksjø RJ, Bernhoff E, Delgado-Blas JF, Brisse S, Correia A, Foster-vold A, Lam MMC, Lunestad BT, Marathe NP, Raffelsberger N, Samuelsen Ø, Sunde M, Sundsfjord A, Urdahl AM, Wick RR, Löhr IH, Holt KE. A genome-wide One Health study of Klebsiella pneumoniae in Norway reveals overlapping populations but few recent trans¬mission events across reservoirs. Genome Med. 2025 Apr 28; 17(1):42. doi: 10.1186/ s13073-025-01466-0. PMID: 40296028; PMCID: PMC12039103.

7. Holmes CL, Dailey KG, Hullahalli K, Wilcox AE, Mason S, Moricz BS, Unverdorben LV, Balazs GI, Waldor MK, Bachman MA. Pat-terns of Klebsiella pneumoniae bacteremic dissemination from the lung. Nat Commun. 2025 Jan 17;16(1):785. doi: 10.1038/s41467-025-56095-3. PMID: 39824859; PMCID: PMC11742683.

8. Hou Y, Zarodkiewicz P, Cortázar JT, Stoner D, Tulauskas Z, Macori G, Valvano MA, Ingram R, McClean S. Protective efficacy of two novel Klebsiella pneumoniae vaccine an-tigens, LysM/BON and OMPP1, in a murine model. Vaccine. 2025 Nov 14;66:127844. doi: 10.1016/j.vaccine.2025.127844. Epub 2025 Oct 13. PMID: 41086758.

9. Hou Y, Zarodkiewicz P, Cortázar JT, Stoner D, Tulauskas Z, Macori G, Valvano MA, Ingram R, McClean S. Protective efficacy of two novel Klebsiella pneumoniae vaccine an-tigens, LysM/BON and OMPP1, in a murine model. Vaccine. 2025 Nov 14;66:127844. doi: 10.1016/j.vaccine.2025.127844. Epub 2025 Oct 13. PMID: 41086758.

10. Huang J, Alhejaili AY, Alkherd UH, Milner M, Zhou G, Alzahrani D, Banzhaf M, Al-zaidi AA, Rajeh AA, Al-Otaiby MA, Alabbad SS, Bukhari D, Aljurayan AN, Aljasham AT, Alze-yadi ZA, Alajel SM, Hong PY, Alghoribi M, Al-mutairi MM, Pain A, Salem WA, Moradigara-vand D. The dissemination of multidrug-resis¬tant and hypervirulent Klebsiella pneumoniae clones across the Kingdom of Saudi Arabia. Emerg Microbes Infect. 2024 Dec; 13(1): 2427793. doi: 10.1080/22221751.2024.242 7793. Epub 2024 Nov 21. PMID: 39508718; PMCID: PMC11583321.

11. Karampatakis T, Tsergouli K, Lowrie K. Efficacy and safety of ceftazidime-avibac¬tam compared to other antimicrobials for the treatment of infections caused by carbape¬nem-resistant Klebsiella pneumoniae strains, a systematic review and meta-analysis. Mic¬rob Pathog. 2023 Jun;179:106090. doi: 10.1016/j.micpath.2023.106090. Epub 2023 Mar 31. PMID: 37004964.

12. Kou X, Yang X, Zheng R. Challenges and opportunities of phage therapy for Klebsi¬ella pneumoniae infections. Appl Environ Mic¬robiol. 2024 Oct 23;90(10):e0135324. doi: 10.1128/aem.01353-24. Epub 2024 Sep 30. PMID: 39345202; PMCID: PMC11497816.

13. Lei TY, Liao BB, Yang LR, Wang Y, Chen XB. Hypervirulent and carbapenem-re-sistant Klebsiella pneumoniae: A global public health threat. Microbiol Res. 2024 Nov; 288:127839. doi: 10.1016/j.mic¬res.2024.12 7839. Epub 2024 Aug 11. PMID: 39141971.

14. Li D, Huang X, Rao H, Yu H, Long S, Li Y, Zhang J. Klebsiella pneumoniae bacteremia mortality: a systematic review and meta-analysis. Front Cell Infect Microbiol. 2023 Apr 20; 13:1157010. doi: 10.3389/fcimb.2023. 1157010. PMID: 37153146; PMCID: PMC1015 9367.

15. Lopatto EDB, Pinkner JS, Sanick DA, Potter RF, Liu LX, Bazán Villicaña J, Tamadon-far KO, Ye Y, Zimmerman MI, Gualberto NC, Dodson KW, Janetka JW, Hunstad DA, Hultgren SJ. Conformational ensembles in Klebsiella pneumoniae FimH impact uropatho¬genesis. Proc Natl Acad Sci U S A. 2024 Sep 24; 121(39):e2409655121. doi: 10.1073/pnas.24 09655121. Epub 2024 Sep 17. PMID: 3928 8182; PMCID: PMC11441496.

16. Russo A, Fusco P, Morrone HL, Tre-carichi EM, Torti C. New advances in manage-ment and treatment of multidrug-resistant Klebsiella pneumoniae. Expert Rev Anti Infect Ther. 2023 Jan; 21(1): 41-55. doi: 10.1080/ 14787210.2023.2151435. Epub 2022 Nov 28. PMID: 36416713.

17. Singh AN, Singh A, Singh SK, Nath G. Klebsiella pneumoniae infections and phage therapy. Indian J Med Microbiol. 2024 Nov-Dec; 52:100736. doi: 10.1016/j.ij¬mmb.2024. 100736. Epub 2024 Oct 5. PMID: 39357832.

18. Urmann E, Stamm P, Wisskirchen J. Cefiderocol bei AML-Patientin mit neutrope-nischem Infekt durch 4MRGN Klebsiella pneu¬moniae (VIM-1) [Cefiderocol in AML patient with neutropenic infection due to 4MRGN Klebsiella pneumoniae (VIM-1)]. Dtsch Med Wochenschr. 2023 Feb;148(4):170-174. Ger¬man. doi: 10.1055/a-1975-2594. Epub 2023 Feb 7. PMID: 36750128.

19. Uzairue LI, Rabaan AA, Adewumi FA, Okolie OJ, Folorunso JB, Bakhrebah MA, Garout M, Alfouzan WA, Halwani MA, Alamri AA, Halawani SA, Alshahrani FS, Hasan A, Mu¬tair AA, Alhumaid S, Etafo J, Utip I, Odoh IM, Uwaezuoke NS. Global Prevalence of Colistin Resistance in Klebsiella pneumoniae from Blo¬odstream Infection: A Systematic Review and Meta-Analysis. Pathogens. 2022 Sep 24; 11 (10):1092. doi:

20. Xu L, Li J, Wu W, Wu X, Ren J. Klebsi-ella pneumoniae capsular polysaccharide: Mechanism in regulation of synthesis, viru-lence, and pathogenicity. Virulence. 2024 Dec; 15(1):2439509. doi: 10.1080/21505594. 2024.2439509. Epub 2024 Dec PMID: 3966 8724; PMCID: PMC11649230.

21. Xu Y, Zhang J, Wang M, Liu M, Liu G, Qu H, Liu J, Deng Z, Sun J, Ou HY, Qu J. Mobili-zation of the nonconjugative virulence plas-mid from hypervirulent Klebsiella pneumo-niae. Genome Med. 2021 Jul 22;13(1):119. doi: 10.1186/s13073-021-00936-5. PMID: 34294 113; PMCID: PMC8299605.

22. Yang P, Liu C, Wu Z, Zheng J, Yi J, Wu N, Wu Z, Lu M, Cui L, Shen N. Klebsiella pneu-moniae infeksiyasiga qarshi davolash qiyin bo'lgan chidamlilik uchun klinik natijalar, mikrobiologik xususiyatlar va xavf omillari. Infeksiya Dori Qarshiligi. 2022 17-ok¬tabr; 15:5959-5969. doi: 10.2147/IDR. S377064. PMID: 36262596; PMCID: PMC9574456.

23. Yu W, Zeng L, Lian X, Jiang L, Xu H, Guo W, Zheng B, Xiao Y. Dynamic cytokine pro¬files of bloodstream infection caused by Kleb¬siella pneumoniae in China. Ann Clin Micro¬biol Antimicrob. 2024 Aug 24;23(1):79. doi: 10.1186/s12941-024-00739-7. PMID: 3918 2143; PMCID: PMC11344948.

24. Zhao M, Li H, Gan D, Wang M, Deng H, Yang QE. Antibacterial effect of phage cock¬tails and phage-antibiotic synergy against pat¬hogenic Klebsiella pneumoniae. mSystems. 2024 Sep 17; 9(9):e0060724. doi: 10.1128/ msystems.00607-24. Epub 2024 Aug 21. PMID: 39166877; PMCID: PMC11406915.

25. Zhong C, Lin S, Li Z, Yang X. Charac-terization of carbapenem-resistant Klebsiella pneumoniae in bloodstream infections: antibi¬otic resistance, virulence, and treatment stra¬tegies. Front Cell Infect Microbiol. 2025 Mar 7; 15:1541704. doi: 10.3389/fcimb.2025.154 1704. PMID: 40125512; PMCID: PMC1192 5884.